HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
2005

HOXB13 and Its Role in Colorectal Cancer

Sample size: 53 publication Evidence: moderate

Author Information

Author(s): C Jung, R-S Kim, H Zhang, S-J Lee, H Sheng, P J Loehrer, T A Gardner, M-H Jeng, C Kao

Primary Institution: Indiana University

Hypothesis

The study investigates the role of HOXB13 in colorectal tumorigenesis and its interaction with TCF4.

Conclusion

The downregulation of HOXB13 in colorectal cancer may contribute to tumor growth by disrupting β-catenin/TCF signaling.

Supporting Evidence

  • 62% of colorectal tumors showed diminished expression of HOXB13.
  • HOXB13 downregulated TCF4 and its target gene c-myc at the protein level.
  • Forced expression of HOXB13 suppressed the growth of colorectal cancer cells.

Takeaway

HOXB13 is a gene that helps control cell growth, and when it's not working properly in colorectal cancer, it can lead to more tumor growth.

Methodology

The expression of HOXB13 was evaluated in 53 colorectal tumors and their matching normal tissues using quantitative RT-PCR analysis.

Limitations

The study was limited to colorectal tumors from the distal left colon to rectum, which may not represent all colorectal cancers.

Statistical Information

P-Value

0.02

Confidence Interval

95%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602631

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication